transcranial electrostimulation for analgesiatranscranial electrostimulation for analgesia ifarmteam...
TRANSCRIPT
![Page 1: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/1.jpg)
Transcranial Electrostimulation for Analgesia
iFarm Team 3Elizabeth Esponnette, Brenda Koehler, Eric Reuland, Yaser Shanjani, Eric Trac
Mentors: Bruce Davis, Bill Thatcher
![Page 2: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/2.jpg)
Pain
2
![Page 3: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/3.jpg)
Transcranial Electro‐stimulation (TES)for Analgesia
WHAT IS IT:• Non‐invasive and non‐
pharmacological approach to relieving pain (analgesia)
HOW IT WORKS:• Electro‐stimulation is applied
through two or more electrodes– The exact mechanism is unclear– Likely modulates the nerve fibers
and nociceptors responsible for transmission of pain.
3
![Page 4: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/4.jpg)
Two Niches
Obstructive sleep apnea surgery Cervical spine injury4
![Page 5: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/5.jpg)
What is obstructive sleep apnea?
5
![Page 6: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/6.jpg)
Epidemiology
• 20‐30% of males and 10‐15% of females have or will develop obstructive sleep apnea
• Increased risk through aging• Increased risk if obese• The most severe cases are indicated for sleep apnea surgery called uvulopalatopharyngoplasty
6Source: UpToDate
![Page 7: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/7.jpg)
Obstructive sleep apnea surgery
• General anesthesia has two major components:– Sedation– Analgesia
• TES provides an alternate to opioid induced analgesia– Roughly 20‐25% of sleep apnea surgery patients have adverse reactions to opioids
7
![Page 8: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/8.jpg)
The Need
• 33,000 sleep apnea surgeries per year in US– About 8,000 surgeries have adverse reactions to opioids
• $5‐10k per surgery, covered by insurance• Extended OR time resulting from complications is covered by the hospital
• Additional need from patients with undiagnosed sleep apnea who present for surgery for other conditions
8
![Page 9: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/9.jpg)
Our Vision
• Use during operation for patients indicated for sleep apnea surgery
• Expand use for patients with less severe sleep apnea who present for surgery for other conditions
9
![Page 10: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/10.jpg)
Benefits for Spinal Cord Injury Patients
• Quicker relief, and better maintenance
• Reduced overall costs• Reduction of pain caused depression • Increased energy level• Better sleep• No related deaths or overdoses• Not addictive• No side effects • Most importantly – increased
functionality and productivity
10
![Page 11: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/11.jpg)
Current Alliance & Interest
• VA has set up a team to work with Dr. Nekhendzyand test the device
• Immediate funding for preliminary data findings –up to 1 year
• Estimate strong support from DOD to fund this project – up to $500,000 per year
11
![Page 12: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/12.jpg)
Nearly $18 billion was spent in care of spinal cord injury (SCI) patients in the US, with an estimated $60 billion being
spent globally
Approximately 200,000 US patients12
![Page 13: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/13.jpg)
Benefits for Insurers and Manufacture of SCI Patients
Estimated Cost Comparison
Current SCI costs $90,000 perpatient
TES device $600
Value to Insurer:• Less Costly• Easier set up• Heathier• Quicker pain relief• Large variety of patient populations
to benefit
Value to manufacturer:• Holding initial patient, would open
entire market• Ability to tie device to future apps
13
![Page 14: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/14.jpg)
14
Wearable medical device
![Page 15: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/15.jpg)
Metrics
• Patient safety• Patient centeredness• Outcomes• Value
15
![Page 16: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/16.jpg)
Regulatory PathwayClass I
Class II
Class III
Class II ?
Class I ?
yes
yes
no
no
SubstantiallyEquivalent? 510(k)
PMA
PMA
Transcranial Electrostimulation (TES) or Cranial Electrotherapy Stimulation (CES)
Substantially equivalent to a Class II device?• Electrical Stimulation (CPT 97032):
• Not substantially equivalent• Cranial Electrotherapy Stimulation:
• Not approved. Investigational only
Likely requires a PMA
http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHTransparency/ucm203018.htm
yes
no
16
![Page 17: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/17.jpg)
Key Partners
• key partners: – Hospitals and individual doctors
• key suppliers: – Signal generator device manufacturer and electrode manufacturer
• key resources we will acquire from partners: – Electrical and mechanical components
• key activities partners perform: – Research, clinical studies, evaluation
17
![Page 18: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/18.jpg)
Key Partners
• Motivations for Partnerships: – Facilitating patient treatment– Higher success rate in high risk surgeries
• Optimization and economy: – Attraction of higher number of patients– Higher cash flow
• Reduction of risk and uncertainty:– Obtaining endorsement from hospitals and doctors– Managing supply purchases based on customer’s orders
18
![Page 19: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/19.jpg)
Revenue• Revenue model
– Start in hospitals/doctors’ offices– Move to home use
• Start up– Angel/Crowd Sourcing
• Mainstream– Partners/Venture Capital
• Pricing tactics (Estimated price customer willing to pay)– CPAP device currently selling for $450 ‐ $900 – EPAP devices (nasal devices) $15 ‐ $30– Oral appliances for sleep apnea device $60 ‐ $100
19
![Page 20: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/20.jpg)
Funding options/sources
• Internal– Coulter – Bio‐X
• External– NIH– DoD
20
![Page 21: Transcranial Electrostimulation for AnalgesiaTranscranial Electrostimulation for Analgesia iFarmTeam 3 Elizabeth Esponnette, Brenda Koehler, Eric Reuland, YaserShanjani, Eric Trac](https://reader030.vdocuments.mx/reader030/viewer/2022040221/5e33b554cff9a23c05664c42/html5/thumbnails/21.jpg)
Next Steps
• Closely monitor current studies at Stanford Hospital and VA.
• Learn Stanford's requirements for fundraising, how to set up account.
• Evaluate and arrange revenue streams for continued research: Crowd Sourcing or Mainstream Partner.
• Research FDA requirements and timelines.
21